United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004), klebsiella pneumoniae (unii: 09pa36ct5r) (klebsiella pneumoniae - unii:09pa36ct5r), enterococcus faecalis (unii: 15e04lz9ct) (enterococcus faecalis - unii:15e04lz9ct), streptococcus pneumoniae (unii: bt6u234yr2) (streptococcus pneumoniae - unii:bt6u234yr2), streptococcus agalactiae (unii: 2b3763s671) (streptococcus agalactiae - unii:2b3763s671), streptococcus mutans (unii: 5c7j33mjj1) (streptococcus mutans - unii:5c7j3 - staphylococcus aureus 15 [hp_x] in 1 ml - for temporary relief of symptoms related to upper respiratory infections including fever, irritated throat, swollen glands, inflamed sinus, cough and runny nose.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to upper respiratory infections including fever, irritated throat, swollen glands, inflamed sinus, cough and runny nose.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004), klebsiella pneumoniae (unii: 09pa36ct5r) (klebsiella pneumoniae - unii:09pa36ct5r), enterococcus faecalis (unii: 15e04lz9ct) (enterococcus faecalis - unii:15e04lz9ct), streptococcus pneumoniae (unii: bt6u234yr2) (streptococcus pneumoniae - unii:bt6u234yr2), streptococcus agalactiae (unii: 2b3763s671) (streptococcus agalactiae - unii:2b3763s671), streptococcus mutans (unii: 5c7j33mjj1) (streptococcus mutans - unii:5c7j3 - staphylococcus aureus 15 [hp_x] in 1 ml - for temporary relief of symptoms related to upper respiratory infections including fever, swollen glands, inflamed sinus, cough and runny nose.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to upper respiratory infections including fever, swollen glands, inflamed sinus, cough and runny nose.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004), klebsiella pneumoniae (unii: 09pa36ct5r) (klebsiella pneumoniae - unii:09pa36ct5r), enterococcus faecalis (unii: 15e04lz9ct) (enterococcus faecalis - unii:15e04lz9ct), streptococcus pneumoniae (unii: bt6u234yr2) (streptococcus pneumoniae - unii:bt6u234yr2), streptococcus agalactiae (unii: 2b3763s671) (streptococcus agalactiae - unii:2b3763s671), streptococcus mutans (unii: 5c7j33mjj1) (streptococcus mutans - unii:5c7j3 - staphylococcus aureus 15 [hp_x] - for temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004), klebsiella pneumoniae (unii: 09pa36ct5r) (klebsiella pneumoniae - unii:09pa36ct5r), enterococcus faecalis (unii: 15e04lz9ct) (enterococcus faecalis - unii:15e04lz9ct), streptococcus pneumoniae (unii: bt6u234yr2) (streptococcus pneumoniae - unii:bt6u234yr2), streptococcus agalactiae (unii: 2b3763s671) (streptococcus agalactiae - unii:2b3763s671), streptococcus mutans (unii: 5c7j33mjj1) (streptococcus mutans - unii:5c7j33mjj1), haemophilus influenzae type b (unii: f2tw0n64fi) (haemophilus influenzae type b - unii:f2tw0n64fi), streptococcus viridans group (unii: nnv2379hkr) (streptococcus viridans group - unii:nnv2379hkr) - staphylococcus aureus 15 [hp_x] in 1 ml - for temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004) - staphylococcus aureus 6 [hp_x] in 10 ml - homeopathic medicine 0.34 fl oz (10 ml) for temporary relief of acne, boils & abscesses.

United States - English - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004) - staphylococcus aureus 5 [hp_x] in 1 ml - oral homeopathic medicine 10 doses, each 1 ml (.03 fl oz) for temporary relief of acne.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004) - staphylococcus aureus 15 [hp_x]

European Union - English - EMA (European Medicines Agency)

laboratorios hipra s.a. - escherichia coli j5 inactivated, staphylococcus aureus (cp8) strain sp 140 inactivated, expressing slime-associated antigenic complex - immunologicals for bovidae - cattle (cows and heifers) - for herd immunisation of healthy cows and heifers, in dairy cattle herds with recurring mastitis problems, to reduce the incidence of sub-clinical mastitis and the incidence and the severity of the clinical signs of clinical mastitis caused by staphylococcus aureus, coliforms and coagulase-negative staphylococci.the full immunisation scheme induces immunity from approximately day 13 after the first injection until approximately day 78 after the third injection (equivalent to 130 days post-parturition).

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004), klebsiella pneumoniae (unii: 09pa36ct5r) (klebsiella pneumoniae - unii:09pa36ct5r), enterococcus faecalis (unii: 15e04lz9ct) (enterococcus faecalis - unii:15e04lz9ct), streptococcus pneumoniae (unii: bt6u234yr2) (streptococcus pneumoniae - unii:bt6u234yr2), streptococcus agalactiae (unii: 2b3763s671) (streptococcus agalactiae - unii:2b3763s671), streptococcus mutans (unii: 5c7j33mjj1) (streptococcus mutans - unii:5c7j3 - staphylococcus aureus 15 [hp_x] - for temporary relief of symptoms related to upper respiratory infections including fever, irritated throat, swollen glands, inflamed sinus, cough and runny nose. for temporary relief of symptoms related to upper respiratory infections including fever, irritated throat, swollen glands, inflamed sinus, cough and runny nose.

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - potassium clavulanate, quantity: 151.917 mg; amoxicillin trihydrate, quantity: 573.892 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; dichloromethane; isopropyl alcohol; sodium starch glycollate; titanium dioxide; hypromellose; macrogol 400 - comox 500/125 tablets are indicated for short-term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (complicated and uncomplicated),lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis,upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.,skin and skin structure infection.,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to amoxicillin and clavulanic acid tablets preparations should not require the addition of another antibiotic due to the amoxicillin content of these products.